Clinical utilization of cinacalcet in hypercalcemic conditions

Research output: Contribution to journalArticlepeer-review


Introduction: Cinacalcet has recently been introduced as a treatment for secondary hyperparathyroidism in dialysis patients and for parathyroid carcinoma. However, there has been an increasing interest in finding out whether cinacalcet can be used as a treatment for other parathyroid hormone (PTH)-dependent hypercalcemic conditions also. Areas covered: The article reports the most relevant recent contributions dealing with calcium sensing receptor (CaSR) physiology as well as cinacalcet pharmacokinetics and pharmacodynamics. It also looks at the different hypercalcemic conditions where the use of cinacalcet has been proposed. This article was researched using clinical trials, case reports and outstanding basic research published in the last 3 years (MEDLINE database up to 31 November 2010). It provides the reader with an insight into the many unaddressed issues regarding cinacalcet that need to be resolved before it can be used in newly proposed fields. Expert opinion: Since cinacalcet may not only have an effect on parathyroid CaSR but also on CaSR expressed at bone and renal levels, it can currently only be considered a good alternative to parathyroidectomy in PTH-dependent hypercalcemic conditions when surgical intervention is burdened by a high failure rate or when it can be considered a risky procedure. At present, cinacalcet cannot be considered the first choice treatment in asymptomatic primary hyperparathyroidism or in mild-to-moderate forms of familial hypocalciuric hypocalcemia.

Original languageEnglish
Pages (from-to)517-528
Number of pages12
JournalExpert Opinion on Drug Metabolism and Toxicology
Issue number4
Publication statusPublished - Apr 2011


  • calcium sensing receptor
  • cinacalcet
  • hypercalcemia
  • parathyroid hormone
  • primary hyperparathyroidism
  • renal transplantation

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology


Dive into the research topics of 'Clinical utilization of cinacalcet in hypercalcemic conditions'. Together they form a unique fingerprint.

Cite this